- Journalists Shed Light on Deadly Hantavirus Outbreak and a Crisis in the Nation’s ERs
- Is the horizon still bright for orthodontists?
- The Make America Healthy Again Movement Comes for Hospital Food
- What’s driving physicians to early retirement
- Why Tenet’s CEO says ASCs keep choosing USPI
- 12 recent hospital, health system president exits
- Hospitals embrace rapid opioid treatment in fentanyl era: Study
- Texas systems open 200-bed behavioral health center
- 32 health systems spending $5B on cancer care
- Sanford, North Memorial planned combination adds to Minnesota healthcare deal wave
- Lone Peak Dental Group acquires Arizona practice
- Inside Northwestern Medicine’s battle against surgeon burnout
- UT Austin launches Epic ahead of new academic medical center
- Ohio system names COO
- Buy, sell or fight: The new calculus of health system growth
- OpenAI’s growing healthcare footprint
- Tennessee optometrist pleads guilty to $6.9M Medicare fraud
- Why Cook County Health’s Medicaid coverage loss strategy is drawing attention
- Akron Children’s chosen for former Ohio college campus site
- Surgery Partners doubles down on orthopedics, robotics as total joint growth hits 14.6%
- The growing war over Anthem’s out-of-network penalty policy
- 3 PDS Health headlines to know in 1 week
- Remarks at the Conference on Financial Market Regulation
- Could ASCs help cardiology move past its ‘breaking point’?
- 3 programs expanding the anesthesia workforce in 2026
- Dad Jokes: Remarks at the 13th Annual Conference on Financial Markets Regulation
- UVM Health targets $300M in cuts, outpatient overhaul amid $280M deficit
- Maine behavioral health provider cites industry pressures in merger
- Dentists opening practices in 1 month
- The Aspen Group names new chief commercial officer
- RFK Jr. Launches Plan To Curb Antidepressant 'Overprescription'
- Georgia mental health provider adds after-hours outpatient program
- AI-augmented behavioral health provider Theris launches out of stealth
- 5 data breaches, settlements impacting cardiology
- Maine hospital adds stroke prevention, cardiac imaging services
- As new tech, AI sweeps the marketing world, Eversana Intouch’s new CEO is ‘comfortable in the gray’
- Sanford Health unveils deal to integrate Minnesota-area North Memorial Health, invest $600M
- Trump plans to fire FDA chief Marty Makary: report
- Trump plans to fire FDA chief Marty Makary: report
- Oregon governor signs behavioral health workforce expansion bills amid shortage
- Remarks at the Special Competitive Studies Project AI+ Expo
- Lawmakers, former FDA leaders and more rally behind mifepristone as Supreme Court weighs telemedicine access to abortion pill
- 5 DSOs making headlines
- Plant-Based Foods May Help Lower Risk of High Blood Pressure
- The ACA exchanges dominated Q1 earnings calls. Here's what payer, health system execs had to say
- Targeted Protein Degradation and Novel Modalities: Getting on the Frontline
- Gilead cranks up Yeztugo first-year sales forecast to $1B on 'unprecedented launch trajectory'
- Capricor Therapeutics files breach-of-contract lawsuit against US partner NS Pharma
- Op-ed: It's time to make more strategic bets on AI in healthcare
- Daiichi Sankyo takes $610M profit hit linked to ADC manufacturing overbuild
- Super Shoes Might Increase Risk Of Running Injuries, Study Says
- TV, Movies Offer Flawed Depictions Of Autism, Add To Delayed Diagnosis, Study Says
- Opioid OD Survivors Have Triple Rate Of Repeat Overdoses Than Previously Estimated
- Revisiting Pharma’s tariff reality
- A New Medicare Option For Weight Loss Drugs: What Older Americans Should Know
- Exposure Therapy Can Successfully Ease Peanut Allergies
- Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
- In California Governor Race, Single-Payer Is a Litmus Test. There’s Still No Way To Pay for It.
- AbbVie’s Skyrizi beats out J&J’s Tremfya in April drug ad spending leaderboard
- Johnson & Johnson launches ‘Generation Fine’ depression project
- Pre-launch efforts linked to lasting drug awareness edge: report
- GSK tees up a Modern Family for meningitis messaging
- NYC invests $12M in overdose recovery workforce
- Aspen Dental to pay $2M to settle allegations of violating corporate dentistry laws
- Texas dental practice relocates into 6K-square-foot facility
- Medit launches global orthodontics division, acquires California training institute
- Pennsylvania enacts dental faculty bill
- Cruise Ship Hantavirus Outbreak Kills 3 as WHO Says Risk Is Low
- How policy, reimbursement incentives, could help healthcare address its climate footprint
- Remarks at the 13th Annual Conference on Financial Market Regulation
- 5 best practices for financially integrating behavioral health
- Fierce Pharma Asia—Summit’s surprise interim trial miss; UCB’s $2B Candid buy; J&J’s CAR-T cuts
- Amazon Pharmacy to offer home delivery for Novo Nordisk's Ozempic pill
- New York expands behavioral health data access in EHRs
- Staffing firm Cross Country Healthcare to be acquired by Knox Lane for $437M
- New Hampshire to receive $29.5M in Purdue opioid settlement
- Behavioral health leaders counter HHS ‘overprescribing’ narrative
- Clover Health's MA membership grows 51% year-over-year
- New Study Suggests The Brain Can Continue Learning While In An Unconscious State
- Health Tech Weekly Rundown: Tether rolls out medical AI for phones, wearables; Medaptus launches operational ‘command center’
- Pennsylvania sues Character.ai over AI chatbot allegedly presenting itself as licensed medical professional
- Angelini finds Catalyst for its US growth ambitions with $4.1B buyout
- FDA to reconsider shock rejection of cell therapy Ebvallo. Could uniQure be next?
- Every 1,000 Steps After Surgery Cuts Complication Risk, Study Finds
- Bullying and Politics Fuel Suicide Risk for LGBTQ+ Teens and Young Adults, Survey Finds
- Head Impacts May Disrupt Gut Health Even Without Concussion
- Class of Migraine Drug, CGRP Inhibitors, Has Added Benefit: Reduced Glaucoma Risk
- States Eye Aid to Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- That Discount at the Pharmacy Counter May Pack Hidden Costs
- Trump Promised Cheaper Drugs. Some Prices Dropped. Many Others Shot Up.
- Hims & Hers debuts its first AI care agent to interpret biomarker lab results
- Alnylam rebuked by FDA over efficacy claims on Amvuttra website
- Insulet CEO details ‘Scrubs’ device promotion win as it boosts awareness, education drive
- Oscar Health's profit hits $679M, membership rises in Q1
- Joint Commission, NACHC partner on training, new accreditation for community health centers
- Ardent Health touts outpatient growth, checked labor spend during hectic Q1
- FDA Authorizes Fruit-Flavored Vapes for Adults
- Sanofi asks to pull Tzield bid from FDA's controversial CNPV program: report
- FDA rolls out 1-day assessment pilot in bid to refocus inspection resources
- Nearly 8 in 10 employers say GLP-1 coverage drives up benefit costs: Business Group on Health
- Edibles + Alcohol Combo Poses Driving Risks Missed by Sobriety Tests
- Leapfrog Group's latest safety grades have far fewer low scores since removal of non-participating hospitals
- VR Training Helps Autistic People Navigate Police Encounters
- Novo CEO cites pricing 'sweet spot' as Wegovy pill debuts with $355M quarter
- Weight Loss Surgeries Fall More Than 20% As Patients Turn To GLP-1 Meds, Experts Say
- FDA blocks publication of COVID, shingles vaccine safety studies: NYT
- Bayer diagnoses how to build trust in cell and gene therapies
- Amwell boasts higher than expected renewals, retention despite Q1 revenue decline
- First Psych Ward Stay Signals Long-Term Mental Health Struggles For Nearly All Patients
- Why Melatonin Shouldn't Be A Bedtime Go-To For Kids
- Children Living Near Gas Stations Have Higher Cancer Risk, Study Finds
- The timing is right for psychedelics manufacturer Optimi Health's IPO
- HHS' Healthy Food Agenda Puts Hospitals On Notice About Patients' Meals
- A New Medicare Option for Weight Loss Drugs: What Older Americans Should Know
- Trump’s Drug Strategy Aims To Bolster Addiction Services — Despite Gutting of Government Support
- Inside the gaps in fertility and surrogacy systems
- CVS execs say company on track to meet MA margin goals by 2028
- Facilitating Access to Trump Accounts
- Fixing Failures to Communicate
- Hinge Health lifts 2026 outlook after strong Q1 as it expands to new conditions
- For nonprofit hospitals, pricey management consultants haven't yielded better performances: study
- Supreme Court Issues Stay, Keeping Abortion Pill Mifepristone Available by Mail For Now
- Statement on Proposing Release for Semiannual Reporting
- Quarterly Questions: Statement on the Proposed Amendments to Allow Semiannual Reporting
- Statement on Proposing Semiannual Reporting
- Wellstar partners with BD to implement AI-driven medication management system
- Listen to the Latest ‘KFF Health News Minute’
- Newer Migraine Drugs Reduce Headache Days With Fewer Side Effects
- New Drug Combo Effective Against Treatment-Resistant IBD, Trials Show
- New Warning Labels Might Help People Cut Back On Drinking
- Ozempic Can Curb Cravings in Alcohol Use Disorder, Landmark Trial Finds
- US on the Brink of Losing Measles-free Status, Study Warns
- Delays in Visa Program Threaten Doctor Placements in Underserved Areas
- States Eye Aid To Prop Up Distressed Hospitals Amid Federal Medicaid Cuts
- Supreme Court Puts Brakes on Abortion Pill Restrictions
- FDA Green Lights Expanded Access to Pancreatic Cancer Drug, Daraxonrasib
- Online Misinformation Adding To Americans' Skin Cancer Risk, Survey Finds
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Medtronic’s Updated Mitral Valve, Mosaic Neo, Gets FDA approval
- Social Media Videos, Easy Access Raise Risk of Teen Inhalant Use
- Staff Statement Regarding Pooled Employer Plans
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Sonire Therapeutics Initiates First U.S. Clinical Study of Ultrasound-Guided HIFU Therapy for Pancreatic Cancer
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- Edwards Lifesciences Shares Ten-Year Pivotal Data Supporting Long-Term Durability of Resilia Tissue
- 'Fitspirational' Posts Can Be More Harmful Than Motivational, Review Concludes
- Parents’ Stress Tied to Children’s Mental Health, New Survey Finds
- Surgeon Multitasking Increases Death Risk Of Organ Transplantees
- When Natural Disasters Strike, Another Crisis Hits Those Recovering From Opioid Addiction
- FDA Recalls Several Ghirardelli Powdered Beverages Over Potential Contamination
The once and future President Trump has nominated Dr. Martin Adel Makary to head the Food and Drug Administration. Stanley Goldfarb, an emeritus professor of medicine at the University of Pennsylvania, has just posted a review of Dr. Makary's latest book: Blind Spots:When Medicine Gets It Wrong, and What It Means for Our Health. The review gives you some insight into Dr. Makary's thoughts on health care in America:
https://freebeacon.com/culture/in-search-of-a-second-opinion/
In Search of a Second Opinion
REVIEW: ‘Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health’ by Marty Makary
By Stanley Goldfarb - November 24, 2024When patients turn to professional societies like the AMA or the American College of Physicians or the American Association of Pediatrics for vital health information, one might expect that the information is based on publications in prestigious medical journals of carefully designed and meticulously interpreted studies. Dr. Marty Makary, in his book Blind Spots, shows how wrong these assumptions can be.
Makary is a frequent commentator on health-related topics. He is a surgeon and surgical oncologist at Johns Hopkins Hospital. Blind Spots consists of several examples where the medical establishment has perpetuated a myth often based on a single academic’s opinion that became ingrained in the culture as "truth" despite the flimsiest of evidence. Using examples like avoiding exposure to peanuts in infants, producing an epidemic of peanut allergy, or denying the benefits of hormone replacement therapy in perimenopausal women, resulting in premature deaths and suboptimal health outcomes, Makary proves his case against groupthink in medicine. He goes on to rail against the overuse of antibiotics because of their potential for altering the microbial composition in the GI tract. Recent research shows that this effect of antibiotics may contribute to serious complications, including risks for cancer and cardiovascular disease.
Another section recounts the saga of the treatment of ulcers of the upper GI tract. Ulcer disease was treated as a neuropsychiatric disorder that required behavioral modification and buffering stomach acid to prevent recurrences. The evidence that a particular bacterium caused stomach ulcers was known for several years, but the medical establishment resisted this insight simply because it flew against conventional wisdom. Eventually, Dr. Barry Marshall won the Nobel Prize in medicine for the discovery. He had to induce his own ulcer disease by ingesting the bacteria that he identified to finally convince the skeptics.
Makary also visits the controversy about so-called gender-affirming care for children. This treatment involves drugs that prevent children with confusion about their sexuality from experiencing a normal puberty, administers sex characteristic-altering hormones, and even life-altering surgical procedures like mastectomies. He quotes some of the most thoughtful critics of these procedures, such as Lisa Littman, who first identified the phenomenon of the rapid onset of gender dysphoria when teenage girls first encounter the earliest phases of puberty. Despite overwhelming evidence that she was correct in her idea that these children had a temporary form of juvenile angst, she was effectively "canceled" because the concept undermined the theory of an underlying biological basis for the psychological disorder.
Gender-affirming care is yet another idea that falls into the category of dangerous treatments accepted by the medical establishment despite ongoing proof that it harms many children. Sadly, almost every major American medical society supports gender-affirming care for these troubled children, while several European nations have examined their own experience with this therapy and the published medical evidence with an open mind and now severely restrict its implementation.
Readers will find this book interesting if they have not had much of a background in biomedical science. It is clear, concise, and well-documented. They may ask a few more questions at their yearly checkup, and that is a good thing.
Why do these wrongheaded approaches to medical care exist, and what can be done to prevent their perpetuation? Makary describes the phenomenon of maintaining a closed mind in the face of contravening data but never quite gets to the originating cause of this attitude in the medical establishment. He does make a strong case for the benefit of classical liberal principles, such as freedom of speech and willingness to confront hierarchies as antidotes. But at a time when conformity and groupthink seem to have taken hold of the most recent generations of physicians, Makary nonetheless praises the current young generation as including vigorous disruptors who will challenge the medical status quo. But has he watched the cult-like recitations of new medical students at their white coat ceremonies about land acknowledgments to indigenous people and obeisance to the oppressor/oppressed paradigm of "systemic racism"? They don’t seem likely to challenge anything.
The unwillingness to have an open mind when examining controversial topics or confronting new information suggests a deeper problem. The problem is, in large part, the culture of medical education. More and more, physicians are taught and regurgitate the "facts." Medicine has increasingly focused on doing rather than knowing. The monetary rewards are skewed toward performing procedures and tests. Understanding basic disease mechanisms or evaluating the quality of medical studies are less valued. This is not a new problem, and Makary cites examples of physicians ignoring best practices or new knowledge in favor of traditional approaches going back centuries. It is easy to understand how this attitude predominated in the era when medical science was primitive, and all that existed was opinion. But modern medical science allows physicians to approach clinical problems with a deep understanding of the mechanisms of disease and underlying biomedical science. Despite this, the failure to improve the closed-mindedness is ongoing. The problem has become more acute given the recent trend in training medical students to be social justice warriors rather than rigorous clinical scientists.
Medical students now learn almost exclusively through taking practice exams and studying the answers to the multiple-choice questions that make up the exams. It is virtually unheard of for students to be assigned textbooks or even specific articles in the medical literature and then asked to interpret the information. They chafe when presented with basic science information if its clinical relevance is not immediately obvious. Yet such knowledge is crucial to good medicine.
To develop independent thinking among physicians, the medical curriculum should develop critical thinking skills about biomedical topics, and students recruited to become physicians should be those who embrace such an approach. Instead, students are increasingly chosen based on their agreement with theories of "systemic racism" and "social determinants of health" rather than their potential to become clinical scientists.
Makary believes that among the current crop of trainees are those who will disrupt the modes of thinking that produce the wrongheaded outcomes he describes. I fear he is wrong in his prescription. I think a more active intervention is needed. Undergraduate and graduate medical education need a reform agenda. Deep learning on experimental design, data interpretation, critical reading of the medical literature, and understanding the philosophy of science should replace the many hours currently spent trying to turn young physicians into social workers.
Blind Spots: When Medicine Gets It Wrong, and What It Means for Our Health
by Marty Makary
Bloomsbury Publishing, 288 pp., $28.99
Stanley Goldfarb is an emeritus professor of medicine at the University of Pennsylvania and father of Washington Free Beacon chairman Michael Goldfarb.
In short - med students need training in how to think, instead of what to think.
I couldn't agree more! Cookie-cutter medicine is letting patients everywhere fall through the cracks.
Another fascinating take on Dr. Makary comes from his previous employer and my frequent source in this Forum for Healthcare Headlines.
https://www.medpagetoday.com/washington-watch/fdageneral/113078
Trump's FDA Pick Is MedPage Today's Former Top Editor
— Marty Makary has made a name for himself challenging the medical establishment
President-elect Donald Trump has chosen Marty Makary, MD, MPH, to run the FDA.
Makary served as the editor-in-chief of MedPage Today from January 2020 through the end of 2021.
"FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency," Trump said on Friday, in announcing the nomination on Truth Social.
"He will work under the leadership of Robert F. Kennedy Jr. to, among other things, properly evaluate harmful chemicals poisoning our Nation's food supply and drugs and biologics being given to our Nation's youth, so that we can finally address the Childhood Chronic Disease Epidemic," Trump added.
Trump also announced the nominations of Dave Weldon, MD, for CDC Director and Janette Nesheiwat, MD, for U.S. Surgeon General.
Makary has written three books on medicine and healthcare: Blind Spots, The Price We Pay, and Unaccountable, the last of which was turned into a TV series called "The Resident." A theme of all three books is challenging the status quo in medicine, questioning the evidence base for certain treatments and established clinical practices. Among his top issues, Makary has taken on the high costs of healthcare and medicine's penchant for overtreatment. He also authored Mama Maggie, a book about a woman who aids the poor people of Egypt's slums.
Early in the COVID-19 pandemic, Makary espoused some views that were in opposition to mainstream medicine, including championing the power of natural immunity, challenging vaccine mandates, and questioning the need for COVID vaccines in children. Makary famously predicted in February 2021 that the U.S. would have "herd immunity by April" 2021.
In 2023, Makary testified before Congress that a lab leak origin of SARS-CoV-2 from the Wuhan Institute of Virology in China was a "no-brainer."
More recently, he has reverted to speaking out against the core business-of-healthcare issues that initially sparked his rise to fame, including how hospitals that make profits should pay taxes, and exposing how certain Medicare policies enable hospital and health system monopolies.
Makary completed his surgical residency at Georgetown University Hospital in Washington, D.C., after attending medical school at Thomas Jefferson University in Philadelphia. He received his Master of Public Health degree from Harvard University. In 2018 he was elected to the National Academy of Medicine.
At FDA, Makary would be in charge of the agency's annual budget of $7 billion, and he would report to Kennedy, Trump's pick for HHS secretary, if confirmed by the Senate.
Late last month, Kennedy lashed out at the FDA in a post on X: "FDA's war on public health is about to end. This includes its aggressive suppression of psychedelics, peptides, stem cells, raw milk, hyperbaric therapies, chelating compounds, ivermectin, hydroxychloroquine, vitamins, clean foods, sunshine, exercise, nutraceuticals, and anything else that advances human health and can't be patented by Pharma. If you work for the FDA and are part of this corrupt system, I have two messages for you: 1. Preserve your records, and 2. Pack your bags."
Outgoing FDA Commissioner Robert Califf, MD, has fought against medical misinformation, and pushed for improvements in food safety and inspections. He recently said that under a Trump administration, FDA's ability to hire and retain skilled employees could be in jeopardy, given Kennedy's hostility to civil servants.
Dr. Martin Adel Makary is now the Commissioner of the Food and Drug Administration:
https://thehill.com/homenews/administration/5214293-senate-confirms-marty-makary-fda/
Senate confirms Marty Makary to lead FDA
By Nathaniel Weixel - March 25, 2025The Senate on Tuesday night confirmed Marty Makary to be the Food and Drug Administration commissioner.
Makary was easily confirmed by a 56-44 vote, picking up three Democrats.
Democratic Sens. Dick Durbin (Ill.) Maggie Hassan (N.H.) and Jeanne Shaheen (N.H.) voted with all Republicans to confirm Makary.
A Johns Hopkins surgeon, Makary will take over an agency hammered by workforce cuts imposed by Elon Musk’s Department of Government Efficiency.
He will also have to navigate politically tricky decisions on access to the abortion medication mifepristone, as well as about vaccine policy under Health and Human Services Secretary Robert F. Kennedy Jr, a prominent vaccine skeptic.
Democrats hammered Makary during his confirmation hearing on recent moves by the Trump administration to cut FDA staff and pressed him on plans to exercise his authority over mifepristone.
GOP senators urged him to curb access, while Democrats pressed him to keep the current policies in place.
Makary tread carefully in his responses, saying he had no preconceived notions about the drugs and would “take a solid, hard look at the data” about mifepristone’s safety.
Makary was a critic of federal COVID-19 mitigation policies and frequently appeared on Fox News during the pandemic.
Makary during his hearing largely said he supported the benefits of vaccines, even as he was being pressed about the recent cancellation of agency advisory panels.
“Vaccines save lives, and I do believe that any child who dies of a vaccine-preventable illness is a tragedy in the modern era,” he said.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.













